10-Q quarterly report · filed Nov 6, 2026

Genpact LTD (G) Q3 2026 10-Q Quarterly Report

Short answer

Genpact LTD (G) filed its Q3 2026 10-Q quarterly report on Nov 6, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $1.4B (up 7.3% year over year) with net income of $152M.

Q3 2026 key financials · XBRL

Revenue
$1.4B
+7.3% YoY · +3.1% QoQ
Net income
$152M
+4.0% YoY · +4.1% QoQ
Operating margin
15.2%
Gross margin
38.0%
EPS (diluted)
$0.90
+8.4% YoY · +5.9% QoQ

Source: XBRL data from the Genpact LTD (G) Q3 2026 10-Q on SEC EDGAR. USD.

Genpact LTD Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $1,385.4M, up 7.3% from $1,291.3M YoY
  • Operating margin 15.2% vs 14.8%; net margin 10.9% vs 11.3% YoY
  • Advanced Technology Solutions best performer: $405.1M, up 30.3%; Core Business Services $980.3M, flat
  • Cash $499.1M vs $853.8M; nine-month operating cash flow $142.0M vs $526.2M
  • Headwinds: ERP-related collection delays, wage inflation, slower sales cycles, geopolitical and economic uncertainty

Risk Factors

  • Newly added legal risk: proposed Domestication, expected completion around March 1, 2027, would change shareholder rights from Bermuda to Delaware law
  • Most material financial update: significant transaction costs, mostly incurred regardless of shareholder approval or completion
  • Regulatory tax risk: U.S. Holders with shares valued at $50,000 or more may recognize gain under Section 367(b)
  • Market risk: Genpact Delaware stock may experience different trading volume, volatility, or investor demand after Domestication
  • Financial risk: Domestication could materially increase the Effective Tax Rate and reduce cash available for dividends

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Genpact LTD quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.